APA (7th ed.) Citation

Seervai, R. N. H., Friske, S. K., Chu, E. Y., Phillips, R., Nelson, K. C., Huen, A., . . . Curry, J. L. (2023). The diverse landscape of dermatologic toxicities of non‐immune checkpoint inhibitor monoclonal antibody‐based cancer therapy. Journal of Cutaneous Pathology, 50(1), 72. https://doi.org/10.1111/cup.14327

Chicago Style (17th ed.) Citation

Seervai, Riyad N. H., et al. "The Diverse Landscape of Dermatologic Toxicities of Non‐immune Checkpoint Inhibitor Monoclonal Antibody‐based Cancer Therapy." Journal of Cutaneous Pathology 50, no. 1 (2023): 72. https://doi.org/10.1111/cup.14327.

MLA (9th ed.) Citation

Seervai, Riyad N. H., et al. "The Diverse Landscape of Dermatologic Toxicities of Non‐immune Checkpoint Inhibitor Monoclonal Antibody‐based Cancer Therapy." Journal of Cutaneous Pathology, vol. 50, no. 1, 2023, p. 72, https://doi.org/10.1111/cup.14327.